Insights on the TB Vaccine Treatment Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global TB vaccine treatment market is expected to grow at a significant CAGR during the forecast period (2021-2027). As per the World Health Organization (WHO), in 2020, an estimated 10 million people fell ill with tuberculosis (TB) globally, which includes 5.6 million men, 3.3 million women and 1.1 million children. Globally, the number of patients receiving TB prevention treatment climbed from 1 million in 2015 to 3.6 million in 2019. Government measures and international support to reduce tuberculosis prevalence is contributing to the growth of the global TB vaccine treatment market. As per the World Health Organization (WHO) global tuberculosis (TB) report 2021, in August 2021, there were 25 drugs in Phase I, Phase II, or Phase III trials for the treatment of drug-susceptible TB, MDR-TB, or TB infection.
There are 16 new chemical
entities, two accelerated regulatory approval medications, one drug recently
approved by the US Food and Drug Administration under the limited population
pathway for antibacterial and antifungal treatments, and six repurposed drugs
among these drugs. Several combination regimens involving new or repurposed
drugs, as well as host-directed therapy, are now in Phase II or Phase III trials.
There were 14 vaccine candidates in clinical trials as of August 2021, with two
in Phase I, eight in Phase II, and four in Phase III. The bacille
Calmette-Guérin (BCG) vaccine is the only approved vaccination for TB
prevention. The BCG vaccine, which was created about a century ago and is
routinely used, prevent severe types of TB in children. Although results from a
Phase II trial of the M72/AS01E candidate are promising, there is presently no
vaccination that is effective in preventing TB disease in adults, either before
or after exposure to TB infection.
To Request a Sample of our Report on TB Vaccine
Treatment Market: https://www.omrglobal.com/request-sample/tb-vaccine-treatment-market
To tackle TB, India has developed the National Strategic
Plan (NSP) for TB Elimination 2017-2025, which accounts for half a million
global TB mortality. India also established the India TB Research Consortium to
promote the development of TB vaccines and medications. A considerable
percentage of TB patients are seen in developed locations such as North
America. According to the Centers for Disease Control and Prevention, 9,093
cases of TB were reported in the US in 2017. Each patient's treatment costs for
MDR-TB and XDR-TB were around $160,000 and $513,000, respectively. This in
turn, is driving the demand for TB vaccines in the country.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
• Segment
Covered-
·
By Product
• Regions
covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape: Merck &
Co., Inc., Sanofi SA, and GlaxoSmithKline plc, among others.
(Get 15% Discount on Buying this Report)
A
full Report of TB Vaccine Treatment Market is Available @ https://www.omrglobal.com/industry-reports/tb-vaccine-treatment-market
Global TB Vaccine Treatment Market Report by Segment
By Product
·
Immune Vaccine
·
Therapy Vaccine
Global TB Vaccine Treatment Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment